Molecular Characterization of Multidrug-Resistant Shigella flexneri
- PMID: 38435906
- PMCID: PMC10905316
- DOI: 10.7759/cureus.53276
Molecular Characterization of Multidrug-Resistant Shigella flexneri
Abstract
Due to their propensity for causing diarrheal illnesses and their rising susceptibility to antimicrobials, Shigella infections constitute a serious threat to global public health. This extensive study explores the frequency, antibiotic resistance, genetic evolution, and effects of Shigella infections on vulnerable groups. The research covers a wide range of geographical areas and sheds information on how the prevalence of Shigella species is evolving. Shigella strain antimicrobial resistance patterns are thoroughly examined. Multidrug resistance (MDR) has been found to often occur in investigations, especially when older antimicrobials are used. The improper use of antibiotics in China is blamed for the quick emergence of resistance, and variations in resistance rates have been seen across different geographical areas. Shigella strains' genetic makeup can be used to identify emerging trends and horizontal gene transfer's acquisition of resistance genes. Notably, S. sonnei exhibits the capacity to obtain resistance genes from nearby bacteria, increasing its capacity for infection. The study also emphasizes the difficulties in accurately serotyping Shigella strains due to inconsistencies between molecular and conventional serology. These results highlight the necessity of reliable diagnostic methods for monitoring Shigella infections. In conclusion, this study emphasizes how dynamic Shigella infections are, with varying patterns of occurrence, changing resistance landscapes, and genetic adaptability. In addition to tackling the rising problem of antibiotic resistance in Shigella infections, these findings are essential for guiding efforts for disease surveillance, prevention, and treatment.
Keywords: antibiotic resistance; human population genetics; multidrug resistant (mdr); multidrug-resistant organism (mdro); shigella.
Copyright © 2024, Satija et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Antibiotic resistance and serotype distribution of Shigella strains in Bangladesh over the period of 2014-2022: evidence from a nationwide hospital-based surveillance for cholera and other diarrheal diseases.Microbiol Spectr. 2024 Nov 14;12(12):e0073924. doi: 10.1128/spectrum.00739-24. Online ahead of print. Microbiol Spectr. 2024. PMID: 39540737 Free PMC article.
-
Concordance between Genotypic and Phenotypic Drug-Resistant Profiles of Shigella Isolates from Taiyuan City, Shanxi Province, China, 2005 to 2016.Microbiol Spectr. 2023 Jun 15;11(3):e0011923. doi: 10.1128/spectrum.00119-23. Epub 2023 May 30. Microbiol Spectr. 2023. PMID: 37249442 Free PMC article.
-
Phylogenetic and Evolutionary Analysis Reveals the Recent Dominance of Ciprofloxacin-Resistant Shigella sonnei and Local Persistence of S. flexneri Clones in India.mSphere. 2020 Oct 7;5(5):e00569-20. doi: 10.1128/mSphere.00569-20. mSphere. 2020. PMID: 33028681 Free PMC article.
-
Dissemination of Multidrug-Resistant Shigella flexneri and Shigella sonnei with Class 1, Class 2, and Atypical Class 1 Integrons in China.Microb Drug Resist. 2019 Dec;25(10):1465-1474. doi: 10.1089/mdr.2018.0229. Epub 2019 Aug 1. Microb Drug Resist. 2019. PMID: 31369341
-
Prevalence of Multidrug-Resistant and Extended-Spectrum Beta-Lactamase-Producing Shigella Species in Asia: A Systematic Review and Meta-Analysis.Antibiotics (Basel). 2022 Nov 18;11(11):1653. doi: 10.3390/antibiotics11111653. Antibiotics (Basel). 2022. PMID: 36421297 Free PMC article. Review.
References
-
- Molecular characterisation of quinolone-resistant Shigella strains isolated in Tehran, Iran. Ranjbar R, Behnood V, Memariani H, Najafi A, Moghbeli M, Mammina C. J Glob Antimicrob Resist. 2016;5:26–30. - PubMed
-
- Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009. Gu B, Cao Y, Pan S, et al. Int J Antimicrob Agents. 2012;40:9–17. - PubMed
-
- Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea. Kim JY, Kim SH, Jeon SM, Park MS, Rhie HG, Lee BK. Clin Microbiol Infect. 2008;14:760–765. - PubMed
-
- Antimicrobial resistance in Shigella spp. causing traveller's diarrhoea (1995-2010): a retrospective analysis. Pons MJ, Gomes C, Martínez-Puchol S, et al. Travel Med Infect Dis. 2013;11:315–319. - PubMed
Publication types
LinkOut - more resources
Full Text Sources